Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. (ETON) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
eton · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$57.00
Consensus
$57.00
+90.3% upside
Low
$57.00
Median: $57 · Last Close: $29.95
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $28.45 | ↓ 5.00% |
1-day model range: $28.19–$28.72. Peak: $28.72 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $66 | +120.0% |
| 2028 | $109 | +265.2% |
| 2029 | $149 | +397.8% |
| 2030 | $179 | +497.1% |
| 2031 | — | +562.7% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ETON · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-20 | Craig-Hallum | Maintains | Buy→Buy |
| 2026-03-20 | B. Riley Securities | Maintains | Buy→Buy |
| 2026-03-03 | Craig-Hallum | Maintains | Buy→Buy |
| 2026-03-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-16 | B. Riley Securities | Maintains | Buy→Buy |
| 2025-05-14 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Eton Pharmaceuticals, Inc. (ETON) stock. Of the recent 38 rating actions, 0 were upgrades and 0 were downgrades. 6 analysts currently cover ETON.
Analyst Recommendation Trends
ETON analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$113M
↓ 53.5% YoY
Revenue Next Year
$183M
↑ 61.0% YoY
EPS This Year
$0.80
EPS Next Year
$1.90
↑ 136.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast ETON EPS of $0.80 for the current fiscal year, based on estimates from 2 analysts. The ETON revenue forecast is $113M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ETON stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ETON price target is $57.00 (+90.3% upside), with an analyst consensus of Buy.
The ETON short-term stock prediction for tomorrow is $28.45 (-5.00%). The ETON stock price prediction for 2027 estimates an average of $66. The ETON stock prediction for 2030 projects a range of $161–$197.
Eton Pharmaceuticals, Inc. trades on NASDAQ under the ticker ETON. The ETON stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
ETON forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month ETON price target is $57.00, with a high forecast of $57.00 and a low of $57.00. The median price target is shown in the chart above when available. This implies +90.3% potential upside from the current price of $29.95.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.